CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-06-18

Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation

Ziel

Epidemiological evidence has established a link between cardiovascular disease and exposure of the heart and major vessels to doses above 500mGy. At lower doses the evidence for a detrimental effect is inconclusive. In part, this is due to the lack of appropriate epidemiological studies, coupled with lack of knowledge of the processes involved that is needed for construction of mathematical models. The ProCardio consortium will study cardiovascular outcomes in childhood cancer survivors where the radiation doses given to the heart are available. These data will be interrogated using new mathematical models developed from the data from our molecular and biological studies. These will use state-of-the-art technologies to map cardiovascular changes after photon irradiation at both low doses and low dose rates. This will be complemented by comparative studies using high LET irradiation. We will apply an integrative approach to combine transcriptional (mRNA and miRNA) and translational (proteomics) studies to understand the disease processes. High throughput proteomics (ICPL, SILAC and label-free analysis) will be used to identify new biomarkers of radiation-induced cardiovascular disease for future molecular epidemiological studies. These will be validated using the archives of cardiovascular tissue samples from the Mayak facility.

Aufforderung zur Vorschlagseinreichung

FP7-Fission-2011
Andere Projekte für diesen Aufruf anzeigen

Koordinator

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
EU-Beitrag
€ 679 796,00
Adresse
INGOLSTADTER LANDSTRASSE 1
85764 Neuherberg
Deutschland

Auf der Karte ansehen

Region
Bayern Oberbayern München, Landkreis
Aktivitätstyp
Research Organisations
Kontakt Verwaltung
Jürgen Ertel (Dr.)
Links
Gesamtkosten
Keine Daten

Beteiligte (12)